FULLERTON, Calif.–(BUSINESS WIRE)–Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California is grateful for a transformative year and proudly reflects on unprecedented succ…
Author: Business Wire
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
ECM Therapeutics Announces Collaboration with the Louis J. Fox Center at the University of Pittsburgh Vision Institute to Advance Cutting-edge Technology for Optic Nerve Repair
PITTSBURGH–(BUSINESS WIRE)–ECM Therapeutics and Louis J. Fox Center at the University of Pittsburgh collaborate to advance cutting-edge technology for optic nerve repair
Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced positive top-line res…
EyeSouth Partners Affiliates With Atlantic Eye Institute, Representing The Network’s 39th Affiliation and Ninth in Florida
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is excited to announce that it has partnered with Atlantic Eye Institute, representing its ninth affiliation in Florida and 39th affiliation overall. EyeSouth is an eye care-focu…
Nordic Pharma Group B.V., par le biais de sa filiale Amring Pharmaceuticals Inc., finalise l'acquisition de Visant Medical pour lancer une thérapie novatrice contre la sécheresse oculaire aux États-Unis
BERWYN, Pennsylvanie–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), une filiale de Nordic Group B.V. (Nordic Pharma), annonce aujourd’hui avoir finalisé l’acquisition de Visant Medical, Inc. (Visant), une chef de file dans l’innovation des tec…
Riassunto: Nordic Pharma Group B.V. completa, tramite la propria affiliata Amring Pharmaceuticals Inc., l’acquisizione di Visant Medical finalizzata al lancio di un’innovativa terapia della sindrome dell’occhio secco negli Stati Uniti
BERWYN, Pennsylvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), un’affiliata di Nordic Group B.V. (Nordic Pharma), oggi ha annunciato di avere completato l’acquisizione di Visant Medical, Inc. (Visant), un leader nell’innovazione medico-te…
Resumen: Nordic Pharma Group B.V., con su filial Amring Pharmaceuticals Inc., cierra la adquisición de Visant Medical para presentar un tratamiento novedoso contra la sequedad ocular en Estados Unidos
BERWYN, Pensilvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), filial de Nordic Group B.V. (Nordic Pharma), ha anunciado hoy que se ha concretado la adquisición de Visant Medical, Inc. (Visant), líder en innovación de tecnología médica par…
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, December 19, 2023, at 8:00 a.m. (ET) to provide top-line results from a Phase 2 clinical trial…
Samenvatting: Nordic Pharma Group B.V. rondt via haar dochteronderneming Amring Pharmaceuticals Inc. de overname af van Visant Medical en lanceert een nieuwe therapie voor droge-ogenziekte in de Verenigde Staten
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), een dochteronderneming van Nordic Group B.V. (Nordic Pharma), kondigde vandaag aan dat de overname van Visant Medical, Inc. (Visant) is afgerond. Visant Medical is een toonaangevend be…
Nordic Pharma Group B.V. schließt über ihre Tochtergesellschaft Amring Pharmaceuticals Inc. die Übernahme von Visant Medical ab, um in den Vereinigten Staaten eine neuartige Therapie für trockene Augen einzuführen
BERWYN, Pennsylvania–(BUSINESS WIRE)–Amring Pharmaceuticals Inc. (Amring), eine Tochtergesellschaft der Nordic Group B.V. (Nordic Pharma), gab heute den Abschluss der Übernahme von Visant Medical, Inc. (Visant) bekannt, einem Marktführer im Bereich d…
Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States
BERWYN, Pa.–(BUSINESS WIRE)–Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V. (Nordic Pharma), announces the completion of its acquisition of Visant Medical, Inc.
20/20 Onsite Expands ‘Vision for Boston’ Program to Provide Eye Care to More Schools
BOSTON–(BUSINESS WIRE)–For the fourth consecutive year, 20/20 Onsite, the leading provider of on-site vision care, is partnering with Boston Public Schools, the New England College of Optometry, and Warby Parker to provide vision screenings, eye exam…
Reviewed Returns to CES with Second Annual AccessABILITY Awards
MCLEAN, Va.–(BUSINESS WIRE)–Reviewed, USA TODAY’s consumer product review brand, part of Gannett Co., Inc. (NYSE: GCI) will host its second annual AccessABILITY Awards, honoring the top products designed for consumers with disabilities. Reviewed will…
Kopin Receives Additional $6 Million Order for Thermal Weapon Sight
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical solutions and high performance micro-displays for defense, enterprise, consumer and medical products, today announced it has recei…
Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced positive topline eff…
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today the U….
Global Ophthalmic Imaging Equipment Pipeline Research Report 2023: Analysis by Stages of Development, Segments, Region, Regulatory Path and Key Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive coverage o…
Dieter Schlosser, former CEO of SoftwareOne, joins Eye-Able®
MARGETSHÖCHHEIM, Germany–(BUSINESS WIRE)–Dieter Schlosser, former CEO of SoftwareOne, becomes major investor and new chairman of the Board at Web Inclusion GmbH (Eye-Able®).
VISIE Inc., a Medtech Computer Vision and Spatial Computing Company, Joins NVIDIA Inception to Up Its Computing Power
AUSTIN, Texas–(BUSINESS WIRE)–VISIE Inc., formerly Advanced Scanners, today announced it has joined NVIDIA Inception, a program that empowers early-stage companies revolutionizing industries with technological advancements. VISIE is a medtech growth …